Clinical Trial

Anticholinergics for Cervical Edema in Labor

Study acronym: ACCEL
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-20.
Status change: Not Yet Recruiting → Recruiting 2026-05-04
Trial Details
NCT Number NCT06702670
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Labor Dystocia
Enrollment 200 participants
Start Date 2025-03-25
Primary Completion 2027-03-25 (estimated)
Study Completion 2027-04-09 (estimated)
Updated on ClinicalTrials.gov 2026-05-06